Abstract
1. The demonstration that systemic administration of the CCKA receptor antagonist, devazepide, increases food intake in rats has provided the strongest support for the hypothesis that endogenous peripherally released cholecystokinin (CCK) acts as a satiety factor. However, interpretation of these results has been confounded by the fact that devazepide can enter the brain from the systemic circulation and may increase food intake by a central action. The present study was therefore undertaken to confirm the hypothesis that endogenous peripheral CCK is a satiety factor by investigating the effects of a novel CCKA receptor antagonist, 2-NAP, which is unlikely to cross the blood brain barrier, on food intake in rats. 2. 2-NAP (1-16 mg kg-1, i.p.) had no significant effects on the intake of a test meal in rats. 3. Pretreatment of rats with 2-NAP (2 mg kg-1, s.c.) abolished the inhibitory effects of exogenous peripheral CCK (5 micrograms kg-1, i.p.) on food intake. 4. In agreement with previous results, devazepide (50-200 micrograms kg-1, i.p.) significantly increased the intake of a test meal in rats. 5. The observations that 2-NAP, which is unlikely to penetrate the blood brain barrier, had no effect on food intake, but that 2-NAP ...Continue Reading
References
Nov 1, 1979·Physiology & Behavior·J D FalascoJ Gibbs
Jul 1, 1991·Neuropeptides·G N WoodruffJ Hughes
Jul 1, 1991·Physiology & Behavior·R L CorwinG P Smith
Sep 1, 1990·Neuroreport·I S Ebenezer
Mar 30, 1990·Science·A WellerJ Gibbs
Jan 1, 1990·Physiology & Behavior·I S EbenezerB A Baldwin
Jul 15, 1990·Biological Psychiatry·O M WolkowitzR A Liddle
Sep 29, 1989·Science·C T DourishS D Iversen
Oct 1, 1987·The Journal of Pharmacy and Pharmacology·R G Pullen, O J Hodgson
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R S Chang, V J Lotti
Jan 1, 1988·British Journal of Pharmacology·G HewsonJ Hughes
Sep 1, 1973·Journal of Comparative and Physiological Psychology·J GibbsG P Smith
Feb 1, 1981·The American Journal of Clinical Nutrition·H R KissileffG P Smith
Jun 10, 1982·Brain Research·E PassaroT Yamada
Jul 1, 1981·Physiology & Behavior·B Gosnell, S Hsiao
Oct 15, 1980·Experientia·C J Savory, M J Gentle
Mar 1, 1993·British Journal of Pharmacology·R A HullJ W Black
Jan 1, 1994·Peptides·J N Crawley, R L Corwin
Jun 1, 1994·Pharmacology, Biochemistry, and Behavior·M Covasa, J M Forbes
Jan 1, 1994·Physiology & Behavior·B A BaldwinV P Gerskowitch
Mar 23, 1994·Annals of the New York Academy of Sciences·G P Smith, J Gibbs
May 1, 1993·Neuroreport·I S Ebenezer, R F Parrott
Citations
Jul 29, 2005·Cellular and Molecular Neurobiology·Rosalinda Guevara-GuzmánRaymond Nowak
May 15, 2002·European Journal of Pharmacology·Ivor S Ebenezer
Feb 15, 2003·European Journal of Pharmacology·Ivor S Ebenezer
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·A P Goursaud, R Nowak
Jan 11, 2001·Peptides·J P VoigtH Fink
Jul 22, 1998·Progress in Neurobiology·B A BaldwinI S Ebenezer
Sep 30, 1999·The Journal of Pharmacy and Pharmacology·T A WoltmanR D Reidelberger
Nov 23, 2007·European Journal of Pharmacology·Jayesh D Patel, Ivor S Ebenezer
Apr 22, 1996·Proceedings. Biological Sciences·I S Ebenezer
Jul 10, 2007·British Journal of Pharmacology·I VerbaeysM Cokelaere
Nov 5, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Roger D ReidelbergerMartin Hulce
May 10, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Roger D ReidelbergerMartin Hulce
Jun 5, 1998·The American Journal of Physiology·J E Cox